Concit Pharma

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Concit Pharma - overview

Established

2011

Location

-, -, Denmark

Primary Industry

Pharmaceuticals

About

Concit Pharma is a Denmark-based company that operates as a developer of drugs for treatment of movements disorders.


Current Investors

SEED Capital, Novo Holdings

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

http://concitpharma.com

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Concit Pharma - financials

Fiscal Year EndedDec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023
Revenue (USD)--------------
% Revenue Growth (YoY)--------------
EBITDA (USD)(6,250)(3,750)(24,377)(9,750)(266,496)5,3096,900,913(9,892)(72,130)(499,306)(37,870)---
Operating Income (USD)(6,250)(3,750)(24,377)(9,750)(266,496)5,3096,900,913(9,892)(72,130)(499,306)(37,870)---
Operating Margin--------------
% EBITDA Margin--------------
NET Income (USD)(6,250)(7,889)(13,712)(12,976)(252,735)132,9016,892,413(13,229)(66,450)(479,134)(18,288)---
% Net Margin--------------

Concit Pharma - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.